Search Results - "Allen, Alina"

Challenges and opportunities in NASH drug development by Harrison, Stephen A., Allen, Alina M., Dubourg, Julie, Noureddin, Mazen, Alkhouri, Naim

“…Nonalcoholic fatty liver disease (NAFLD) and its more severe form, nonalcoholic steatohepatitis (NASH), represent a growing worldwide epidemic and a high unmet…”
Get full text

Healthcare and socioeconomic costs of NAFLD: A global framework to navigate the uncertainties by Allen, Alina M., Lazarus, Jeffrey V., Younossi, Zobair M.

“…Left unaddressed, non-alcoholic fatty liver disease (NAFLD) will continue to have substantial health, economic and social implications. To address the…”
Get full text

Sarcopenia in hiding: The risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis by Bhanji, Rahima A., Narayanan, Praveena, Allen, Alina M., Malhi, Harmeet, Watt, Kymberly D.

“…Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide. Up to one third of individuals with NAFLD will develop…”
Get full text

Reply: Comparing quantitative MRI technologies in steatotic liver disease by Li, Jiahui, Allen, Alina M, Yin, Meng

Get full text

Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies by Singh, Siddharth, Allen, Alina M, Wang, Zhen, Prokop, Larry J, Murad, Mohammad H, Loomba, Rohit

“…Background & Aims Little is known about differences in rates of fibrosis progression between patients with nonalcoholic fatty liver (NAFL) vs nonalcoholic…”
Get full text

The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity – A longitudinal cohort study by Allen, Alina M., Hicks, Stephen B., Mara, Kristin C., Larson, Joseph J., Therneau, Terry M.

“…[Display omitted] •NAFLD is associated with a nearly 2-fold increase in the overall risk of incident cancers.•The highest risk was noted in liver, uterine,…”
Get full text

Nonalcoholic fatty liver disease incidence and impact on metabolic burden and death: A 20 year‐community study by Allen, Alina M., Therneau, Terry M., Larson, Joseph J., Coward, Alexandra, Somers, Virend K., Kamath, Patrick S.

“…Recent population‐based data on nonalcoholic fatty liver disease (NAFLD) epidemiology in general, and incidence in particular, are lacking. We examined trends…”
Get full text

Diabetes Is Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Cirrhosis From Nonalcoholic Fatty Liver Disease by Yang, Ju Dong, Ahmed, Fowsiyo, Mara, Kristin C., Addissie, Benyam D., Allen, Alina M., Gores, Gregory J., Roberts, Lewis R.

“…Diabetes increases the risk of liver disease progression and cirrhosis development in patients with nonalcoholic steatohepatitis (NASH). The association…”
Get full text

Comparative effectiveness of pharmacological interventions for nonalcoholic steatohepatitis: A systematic review and network meta‐analysis by Singh, Siddharth, Khera, Rohan, Allen, Alina M., Murad, M. Hassan, Loomba, Rohit

“…We performed a Bayesian network meta‐analysis combining direct and indirect treatment comparisons to assess the comparative effectiveness of pharmacological…”
Get full text

Disparities in liver transplantation: One size may not fit all by Kwong, Allison J., Allen, Alina M., Heimbach, Julie

Get full text

Improved Prioritization of the Liver Transplant Waitlist: Weighing the Risks by Heimbach, Julie K, Allen, Alina M

Get full text

Liver Stiffness on Magnetic Resonance Elastography and the MEFIB Index and Liver-Related Outcomes in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Individual Participants by Ajmera, Veeral, Kim, Beom Kyung, Yang, Kun, Majzoub, Abdul M., Nayfeh, Tarek, Tamaki, Nobuharu, Izumi, Namiki, Nakajima, Atsushi, Idilman, Ramazan, Gumussoy, Mesut, Oz, Digdem Kuru, Erden, Ayse, Quach, Natalie E., Tu, Xin, Zhang, Xinlian, Noureddin, Mazen, Allen, Alina M., Loomba, Rohit

“…Magnetic resonance elastography (MRE) is an accurate biomarker of liver fibrosis; however, limited data characterize its association with clinical outcomes. We…”
Get full text

Hepatic steatosis provides the terroir that promotes the development of cardiovascular risk factors and disease by Rowe, Ian A, Allen, Alina M

Get full text

Recurrent or De Novo Allograft Steatosis and Long-term Outcomes After Liver Transplantation by Narayanan, Praveena, Mara, Kristin, Izzy, Manhal, Dierkhising, Ross, Heimbach, Julie, Allen, Alina M, Watt, Kymberly D

“…BACKGROUNDHepatic steatosis is strongly associated with cardiovascular disease in the general population. Whether recurrent or de novo, it can occur in the…”
Get full text

Healthcare Cost and Utilization in Nonalcoholic Fatty Liver Disease: Real‐World Data From a Large U.S. Claims Database by Allen, Alina M., Houten, Holly K., Sangaralingham, Lindsey R., Talwalkar, Jayant A., McCoy, Rozalina G.

“…The prevalence of nonalcoholic fatty liver disease (NAFLD) is increasing. The health care burden resulting from the multidisciplinary management of this…”
Get full text

MASLD: a disease in flux by Allen, Alina M., Arab, Juan Pablo, Wong, Vincent Wai-Sun

“…To coincide with the 20th anniversary of Nature Reviews Gastroenterology & Hepatology , we asked three experts to reflect on the past, present and future of…”
Get full text

AGA Clinical Practice Guideline on the Management of Coagulation Disorders in Patients With Cirrhosis by O’Shea, Robert S., Davitkov, Perica, Ko, Cynthia W., Rajasekhar, Anita, Su, Grace L., Sultan, Shahnaz, Allen, Alina M., Falck-Ytter, Yngve

Get full text

Natural History of Nonalcoholic Fatty Liver Disease With Normal Body Mass Index: A Population-Based Study by Ahmed, Omar T., Gidener, Tolga, Mara, Kristin C., Larson, Joseph J., Therneau, Terry M., Allen, Alina M.

“…The natural history of lean nonalcoholic fatty liver disease (NAFLD) is not well-understood. Consequently, patient counseling and disease management are…”
Get full text

Performance of American Gastroenterological Association Clinical Care Pathway for the risk stratification of patients with nonalcoholic fatty liver disease in the US population by Udompap, Prowpanga, Therneau, Terry M, Canning, Rachel E, Benson, Joanne T, Allen, Alina M

“…The American Gastroenterological Association (AGA) recently launched the Clinical Care Pathway for the Risk Stratification and Management of Patients with…”
Get full text

Time trends in the health care burden and mortality of acute on chronic liver failure in the United States by Allen, Alina M., Kim, W. Ray, Moriarty, James P., Shah, Nilay D., Larson, Joseph J., Kamath, Patrick S.

“…Acute on chronic liver failure (ACLF) is associated with multisystem organ failure and poor prognosis in hospitalized patients with cirrhosis. We aimed to…”
Get full text